Macquarie Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-4,770
| Closed | -$170K | – | 1742 |
|
2023
Q1 | $170K | Buy |
4,770
+1,979
| +71% | +$70.5K | ﹤0.01% | 1562 |
|
2022
Q4 | $102K | Sell |
2,791
-1,148,781
| -100% | -$42M | ﹤0.01% | 1645 |
|
2022
Q3 | $54.4M | Buy |
1,151,572
+473,794
| +70% | +$22.4M | 0.07% | 398 |
|
2022
Q2 | $48.6M | Buy |
677,778
+326,529
| +93% | +$23.4M | 0.05% | 465 |
|
2022
Q1 | $28.4K | Sell |
351,249
-93
| -0% | -$8 | 0.02% | 677 |
|
2021
Q4 | $36.1M | Sell |
351,342
-9,791
| -3% | -$1.01M | 0.03% | 593 |
|
2021
Q3 | $31.6M | Buy |
361,133
+551
| +0.2% | +$48.2K | 0.03% | 639 |
|
2021
Q2 | $32.3M | Sell |
360,582
-3,657
| -1% | -$327K | 0.03% | 659 |
|
2021
Q1 | $27.6M | Buy |
364,239
+81,970
| +29% | +$6.22M | 0.04% | 460 |
|
2020
Q4 | $19.2M | Buy |
282,269
+216,403
| +329% | +$14.7M | 0.03% | 532 |
|
2020
Q3 | $3.5M | Buy |
65,866
+3,610
| +6% | +$192K | 0.01% | 905 |
|
2020
Q2 | $3.63M | Buy |
62,256
+1,009
| +2% | +$58.8K | 0.01% | 859 |
|
2020
Q1 | $2.41M | Sell |
61,247
-9,515
| -13% | -$375K | 0.01% | 871 |
|
2019
Q4 | $4.21M | Buy |
70,762
+5,786
| +9% | +$344K | 0.01% | 849 |
|
2019
Q3 | $3.46M | Buy |
64,976
+3,757
| +6% | +$200K | 0.01% | 855 |
|
2019
Q2 | $3.13M | Buy |
61,219
+2,302
| +4% | +$118K | 0.01% | 894 |
|
2019
Q1 | $3.05M | Buy |
58,917
+760
| +1% | +$39.3K | 0.01% | 882 |
|
2018
Q4 | $2.29M | Buy |
58,157
+1,512
| +3% | +$59.5K | ﹤0.01% | 936 |
|
2018
Q3 | $2.92M | Sell |
56,645
-1,610
| -3% | -$83K | ﹤0.01% | 906 |
|
2018
Q2 | $2.73M | Buy |
+58,255
| New | +$2.73M | ﹤0.01% | 923 |
|
2016
Q3 | – | Sell |
-118,366
| Closed | -$4.51M | – | 1595 |
|
2016
Q2 | $4.51M | Buy |
118,366
+45,229
| +62% | +$1.72M | ﹤0.01% | 899 |
|
2016
Q1 | $3.01M | Buy |
+73,137
| New | +$3.01M | 0.01% | 841 |
|